Ensysce Biosciences (ENSCW) Prepaid Assets (2017 - 2025)
Ensysce Biosciences (ENSCW) reported Prepaid Assets of $105091.0 for Q4 2025, down 92.17% year-over-year from $1.3 million in Q4 2024, and down 91.6% quarter-over-quarter from $1.3 million in Q3 2025.
Ensysce Biosciences (ENSCW) Prepaid Assets (2017 - 2025) Analysis & Trends
Ensysce Biosciences (ENSCW) has 9 years of Prepaid Assets data on file, last reported at $105091.0 in Q4 2025.
- Prepaid Assets for Q4 2025 came in at $105091.0, down 92.17% year-over-year; the trailing twelve-month figure through Dec 2025 was $105091.0 (down 92.17% YoY), and the FY2025 annual result was $105091.0, down 92.17% from the prior year.
- Prepaid Assets fell to $105091.0 in Q4 2025 per ENSCW's latest filing, from $1.3 million in the prior quarter.
- Over five years, Prepaid Assets peaked at $3.2 million in Q3 2024 and troughed at $8000.0 in Q3 2023.
- A 5-year average of $1.1 million and a median of $1.2 million in 2024 frame the typical range for Prepaid Assets.
- The sharpest annual moves came in 2023 and 2024: Prepaid Assets sank 98.55% in 2023, then jumped 39326.38% in 2024.
- A 5-year view of Prepaid Assets shows it stood at $733234.0 in 2021, then surged by 151.96% to $1.8 million in 2022, then tumbled by 42.21% to $1.1 million in 2023, then rose by 25.73% to $1.3 million in 2024, then tumbled by 92.17% to $105091.0 in 2025.
- Business Quant data shows ENSCW's Prepaid Assets at $105091.0 in Q4 2025, $1.3 million in Q3 2025, and $1.9 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Ensysce Biosciences | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 105,091.00 |
| Sep 30, 2025 | 1.25 Mn |
| Jun 30, 2025 | 1.87 Mn |
| Mar 31, 2025 | 1.33 Mn |
| Dec 31, 2024 | 1.34 Mn |
| Sep 30, 2024 | 3.15 Mn |
| Jun 30, 2024 | 1.19 Mn |
| Mar 31, 2024 | 1.20 Mn |
| Dec 31, 2023 | 1.07 Mn |
| Sep 30, 2023 | 8,000.00 |
| Jun 30, 2023 | 678,285.00 |
| Mar 31, 2023 | 1.65 Mn |
| Dec 31, 2022 | 1.85 Mn |
| Sep 30, 2022 | 550,634.00 |
| Jun 30, 2022 | 681,851.00 |
| Mar 31, 2022 | 1.79 Mn |
| Dec 31, 2021 | 733,234.00 |
| Sep 30, 2021 | 1.96 Mn |
| Jun 30, 2021 | 179,569.00 |
| Mar 31, 2021 | 190,400.00 |